Literature DB >> 23960851

Diabetic macular edema.

Einar Stefánsson1.   

Abstract

A variety of treatment options are available for the treatment of diabetic macular edema. They include laser photocoagulation, anti-VEGF drugs, intravitreal steroids, and vitrectomy with or without release of vitreoretinal traction. A full understanding of the physiological mechanisms of these treatment modalities allows sensible combination of treatment options. Retinal photocoagulation has repeatedly been shown to improve retinal oxygenation, as does vitrectomy. Oxygen naturally reduces VEGF production and thereby decreases leakage of plasma proteins from capillaries into the tissue. In addition, vitrectomy allows faster clearance of cytokines, such as VEGF, from the retina into the vitreous cavity. The VEGF-lowering effect of photocoagulation and vitrectomy can be augmented with anti-VEGF drugs and corticosteroids reduce the effect of VEGF on capillary permeability. Starling's law explains vasogenic edema, which is controlled by osmotic and hydrostatic gradients between vessel and tissue. It explains how VEGF-induced vascular permeability causes plasma protein to leak into the tissue interstitial space, thus decreasing the osmotic pressure gradient between vessel and tissue, resulting in water accumulation, i.e. edema. This is reversed by reducing VEGF production, which is achieved with laser treatment; or by removing VEGF with antibodies or vitrectomy; or by reducing the permeability effect with steroids. At the same time, Starling's law takes into account hemodynamic changes that affect the hydrostatic gradient. High arterial blood pressure and hypoxic vasodilatation increase the hydrostatic pressure in the microcirculation, which increases water flux from vessel to tissue and induce edema. Treatment of arterial hypertension or reversal of retinal hypoxia with laser reverses this pathophysiology and reduces edema. Newton's third law explains, that vitreoretinal traction decreases hydrostatic tissue pressure in the retina, increases the pressure gradient between vessel and tissue, and stimulates water fluxes from vessel into tissue, leading to edema. Release of vitreoretinal traction reverses this mechanism and reduces edema.

Entities:  

Keywords:  Edema; Laser treatment; Macular edema; Oxygen; Starling’s law; Steroids; Vascular endothelial growth factor; Vitrectomy; Water

Year:  2009        PMID: 23960851      PMCID: PMC3729484          DOI: 10.1016/j.sjopt.2009.06.002

Source DB:  PubMed          Journal:  Saudi J Ophthalmol        ISSN: 1319-4534


  44 in total

1.  Triple therapy of vitrectomy, intravitreal triamcinolone, and macular laser photocoagulation for intractable diabetic macular edema.

Authors:  Se Woong Kang; Sung Chul Park; Hee Yoon Cho; Jae Hoon Kang
Journal:  Am J Ophthalmol       Date:  2007-10-15       Impact factor: 5.258

2.  Intravitreal triamcinolone for macular oedema: efficacy in relation to aetiology.

Authors:  Torben Lykke Sørensen; Per Haamann; Jørgen Villumsen; Michael Larsen
Journal:  Acta Ophthalmol Scand       Date:  2005-02

3.  Diabetic retinopathy. Screening and prevention of blindness. A doctoral thesis.

Authors:  J K Kristinsson
Journal:  Acta Ophthalmol Scand Suppl       Date:  1997

4.  Laser-induced changes in intraretinal oxygen distribution in pigmented rabbits.

Authors:  Dao-Yi Yu; Stephen J Cringle; Erning Su; Paula K Yu; Mark S Humayun; Giorgio Dorin
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-03       Impact factor: 4.799

5.  The therapeutic effects of retinal laser treatment and vitrectomy. A theory based on oxygen and vascular physiology.

Authors:  E Stefánsson
Journal:  Acta Ophthalmol Scand       Date:  2001-10

6.  Intravitreal triamcinolone acetonide for diffuse diabetic macular oedema: 6-month results of a prospective controlled trial.

Authors:  François Audren; Ali Erginay; Belkacem Haouchine; Rym Benosman; John Conrath; Jean-François Bergmann; Alain Gaudric; Pascale Massin
Journal:  Acta Ophthalmol Scand       Date:  2006-10

7.  Corticosteroids inhibit VEGF-induced vascular leakage in a rabbit model of blood-retinal and blood-aqueous barrier breakdown.

Authors:  Jeffrey L Edelman; David Lutz; Marisol R Castro
Journal:  Exp Eye Res       Date:  2005-02       Impact factor: 3.467

Review 8.  Intravitreal steroids in the management of macular oedema.

Authors:  Sobha Sivaprasad; Peter McCluskey; Susan Lightman
Journal:  Acta Ophthalmol Scand       Date:  2006-12

Review 9.  Intravitreal triamcinolone for the treatment of diabetic macular edema.

Authors:  Francisco Gómez-Ulla; Joaquín Marticorena; D Virgil Alfaro; Maribel Fernández; Elizabeth Rodríguez Méndez; Michelle Rothen
Journal:  Curr Diabetes Rev       Date:  2006-02

10.  Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema.

Authors:  Daniel Kook; Atmin Wolf; Thomas Kreutzer; Aljoscha Neubauer; Rupert Strauss; Michael Ulbig; Anslem Kampik; Christos Haritoglou
Journal:  Retina       Date:  2008-10       Impact factor: 4.256

View more
  1 in total

1.  Adverse Events during Vitreoretinal Surgery under Adequacy of Anesthesia Guidance-Risk Factor Analysis.

Authors:  Michał Jan Stasiowski; Aleksandra Pluta; Anita Lyssek-Boroń; Seweryn Król; Lech Krawczyk; Ewa Niewiadomska; Jakub Żak; Magdalena Kawka; Dariusz Dobrowolski; Beniamin Oskar Grabarek; Izabela Szumera; Michael Janusz Koss; Anna Missir; Robert Rejdak; Przemysław Jałowiecki
Journal:  Pharmaceuticals (Basel)       Date:  2022-02-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.